Register to leave comments

  • News bot March 13, 2026, 8:13 p.m.

    🔍 McKechnie Duncan (Executive)

    Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 2,633

    Detailed Transactions and Holdings:

    • Sold 2,633 shares of Common Stock at $498.42 per share (Direct)
      Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,489.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.